Zymeworks (ZYME) Cash & Current Investments (2021 - 2026)

Zymeworks has reported Cash & Current Investments for 6 years, with the latest figure at $364.7 million in Q1 2026.

• Quarterly Cash & Current Investments rose 37.48% year-over-year to $364.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $364.7 million (up 37.48% YoY) and the FY2025 annual result came in at $228.8 million, up 1.34% from the prior year.
• Cash & Current Investments improved to $364.7 million in Q1 2026 per ZYME's latest filing, from $228.8 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $492.2 million in Q4 2022 and troughed at $166.2 million in Q3 2022.
• A 5-year average of $306.6 million and a median of $297.2 million in 2024 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments soared 94.86% in 2022, then plunged 39.68% in 2024.
• Over 5 years, Cash & Current Investments stood at $492.2 million in 2022, then decreased by 23.95% to $374.3 million in 2023, then slumped by 39.68% to $225.8 million in 2024, then grew by 1.34% to $228.8 million in 2025, then jumped by 59.41% to $364.7 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $364.7 million, $228.8 million, and $251.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.